Stephen Toon

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Molecular imaging in drug development

Human P450 metabolism of warfarin

Pharmacology and Management of the Vitamin K Antagonists

Quantitative structure–pharmacokinetic/pharmacodynamic relationships

The 4‐Quinolone Antibiotics: Past, Present, and Future

The Effects of Acetaminophen on Pharmacokinetics and Pharmacodynamics of Warfarin

A review on the fabrication of substrates for surface enhanced Raman spectroscopy and their applications in analytical chemistry

Green Chemistry: Principles and Practice

Chitosan-based hydrogels for controlled, localized drug delivery

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Antithrombotic Therapy for VTE Disease

Pharmacokinetic aspects of biotechnology products

Emergency Hospitalizations for Adverse Drug Events in Older Americans

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

The contribution of clinical pharmacology surrogates and models to drug development—a critical appraisal

The flinders sensitive line rats: A genetic animal model of depression

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Clinical Pharmacokinetics of Ibuprofen

Antithrombotic Therapy for VTE Disease

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development

Mechanisms of drug combinations: interaction and network perspectives

Oral Anticoagulants

Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs

The use of mucoadhesive polymers in buccal drug delivery

Progress in plasmonic engineering of surface-enhanced Raman-scattering substrates toward ultra-trace analysis

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Pharmacogenetics of Warfarin Elimination and its Clinical Implications

Systematic Overview of Warfarin and Its Drug and Food Interactions

Mesoporous Materials for Drug Delivery

The Pharmacology and Management of the Vitamin K Antagonists

Surface‐Enhanced Raman Spectroscopy: Concepts and Chemical Applications

Protein therapeutics: a summary and pharmacological classification

Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins

Mechanism of Quinolone Action and Resistance

Crystal structure of photosystem II from Synechococcus elongatus at 3.8 Å resolution

Chlorophyll Fluorescence: A Probe of Photosynthesis In Vivo

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

A knowledge-based three dimensional model of the Photosystem II reaction center of Chlamydomonas reinhardtii

Chlorophyll a fluorescence induction1Dedicated to Docent Jan Nauš on the occasion of his 50th birthday.1

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

Interparticle Coupling Effect on the Surface Plasmon Resonance of Gold Nanoparticles:  From Theory to Applications

Negative Differential Photoconductance in Gold Nanoparticle Arrays in the Coulomb Blockade Regime

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges

Guidelines for the Primary Prevention of Stroke

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Plasmons in Strongly Coupled Metallic Nanostructures

Dosing Adjustment of 10 Antimicrobials for Patients with Renal Impairment

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Controlling the Synthesis and Assembly of Silver Nanostructures for Plasmonic Applications

Domestication of Chemistry by Design of Safer Chemicals: Structure-Activity Relationships

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Dynamic Inversion of Stereoselective Phosphate Binding to a Bisurea Receptor Controlled by Light and Heat

Interactions of Warfarin with Drugs and Food

Guidelines for Treatment of Candidiasis

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Photopharmacology: Beyond Proof of Principle

Photothermal Nanomaterials: A Powerful Light-to-Heat Converter

Clinical Pharmacokinetics and Pharmacodynamics of Warfarin

The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

Factors Related to Errors in Medication Prescribing

Structure-pharmacokinetic relationships among the barbiturates in the rat.

Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing

Human Transbuccal Absorption of Diclofenac Sodium from a Prototype Hydrogel Delivery Device

The relevance of pharmacokinetics in the development of biotechnology products

Relevance of Pharmacokinetic Studies in Volunteers

The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans

Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man

A Study to Assess The Anticholinergic Activity of Rolipram in Healthy Elderly Volunteers

Further insight into the stereoselective interaction between warfarin and cimetidine in man.

Enoxacin-warfarin interaction: Pharmacokinetic and stereochemical aspects

Stereospecific Assay of Ibuprofen and its Metabolites

The warfarin‐cimetidine interaction: stereochemical considerations.

Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.

The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.

Surface-Enhanced Resonance Raman Scattering Spectroscopy of Photosystem II Pigment-Protein Complexes

The warfarin-sulfinpyrazone interaction: stereochemical considerations

STRUCTURAL AND FUNCTIONAL INTEGRITY OF THE PHOTOSYSTEM II REACTION CENTER ON SILVER ELECTRODES: FLUORESCENCE AND REDOX PROBES

An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.